Welcome to LookChem.com Sign In|Join Free

Hubei Vanz Pharm Co.,Ltd

Diamond Supplier Enterprise Certification

Diamond
Supplier
5th
years
Home>>Products>>CAS 241479-67-4 99% Isavuconazole Powder

Product Certification&
Enterprise Certification

More Detail

Hubei Vanz Pharm Co.,Ltd

Country: China (Mainland)

Business Type:Trading Company

Ms.Chelsea gao

Tel: 86-27-84492310

Ms.Bella Li

Tel: 008618986076206

Ms.Chelsea Gao

Tel: +86 27 84492310

Ms.Wendy

Tel: WhatsApp +8615927784577

Ms.Mirriam

Tel: +8618071739296

Mobile:

Tel: 86-27-84492310

Fax: 86-27-84402310

URL: http://www.vanzpharm.com/en/index.html

Province/state: Hubei

City: JIAYU

Street: FANHU INDUSTRY PARK

MaxCard:


    x
  • Ms.Bella Li
  • Ms.Chelsea Gao
Contact Suppliers

CAS 241479-67-4 99% Isavuconazole Powder

CAS NO.241479-67-4

  • Min.Order: 1 Kilogram
  • Payment Terms: L/C,T/T,MoneyGram
Contact Supplier

Product Details

Keywords

  • Isavuconazole powder
  • Isavuconazole
  • 99% Isavuconazole Powder

Quick Details

  • ProName: CAS 241479-67-4 99% Isavuconazole Powd...
  • CasNo: 241479-67-4
  • Molecular Formula: C22H17F2N5OS
  • Appearance: white
  • Application: anti antiviral
  • DeliveryTime: 7-10 days
  • PackAge: drum
  • Port: Shanghai/Wuhan
  • ProductionCapacity: 1000 Kilogram/Day
  • Purity: 99
  • Storage: room
  • LimitNum: 1 Kilogram

Superiority

 

MOQ: 1kg
Form: Powder
Colour: White
Test: HPLC
Function: anti   antiviral 
Grade: Pharm

 

Details

CAS 241479-67-4 99% Isavuconazole Powder

product Name:    Isavuconazole
CAS:    241479-67-4
MF:    C22H17F2N5OS
MW:    437.47
EINECS:    1592732-453-0 

What is Isavuconazole 
Isavuconazole is a new triazole currently undergoing phase III clinical trials. 
This compound has shown in vitro activity against a large number of clinical important yeasts and molds including Asperg illus spp., Fusarium spp., Scedosporium spp.Candida spp., the Zygomycetes and Cryptococcus spp.

Isavuconazole Function 
1. Invasive aspergillosis: suitable for the treatment of patients with invasive aspergillosis aged 18 years and older.
2. Invasive mucormycosis: suitable for the treatment of patients with invasive mucormycosis aged 18 years and older.